Harrington v. Purdue Pharma L.P.
Headline: Court blocks plan releasing the Sackler family from opioid lawsuits, ruling bankruptcy law does not allow extinguishing non‑bankrupt third‑party claims without victims’ consent, jeopardizing that global settlement effort.
Holding:
- Prevents bankruptcy courts from ordering nonconsensual releases of third‑party defendants.
- Lets victims and governments continue suing Sackler family members over opioid harms.
- Threatens the specific global settlement that pooled billions for abatement and victim payments.
Summary
Background
A prescription‑opioid crisis led to thousands of lawsuits against Purdue Pharma and members of the Sackler family. Between 1999 and 2019 roughly 247,000 people died from prescription‑opioid overdoses, and the Sacklers withdrew about $11 billion from Purdue. Purdue filed for Chapter 11 bankruptcy in 2019. The Sacklers offered to return several billion dollars to the bankruptcy estate in exchange for a judicial order that would release them from present and future opioid claims and stop victims from suing them. The bankruptcy court approved the plan, a district court vacated that approval, a divided Second Circuit revived it, and the United States Trustee appealed to this Court.
Reasoning
The key question was whether the bankruptcy code authorizes a reorganization plan to extinguish claims against nonbankrupt third parties without the claimants’ consent. The majority said no. It relied on the text and structure of §1123 and related discharge rules, applied ordinary interpretive canons, and emphasized that discharge normally belongs to the debtor who places most assets on the table. The Court concluded the catchall in §1123(b)(6) cannot be read to give bankruptcy courts a sweeping power to grant nonconsensual third‑party discharges. The opinion stressed its holding is narrow and does not forbid consensual third‑party releases.
Real world impact
The decision removes the legal basis for the specific nonconsensual “Sackler discharge” and sends the case back for further proceedings. Victims, states, and local governments may resume separate claims against the Sacklers, and the particular global settlement that pooled billions for abatement and victim payments is now in jeopardy. The Court left open questions about plans already finalized and how consensual releases work.
Dissents or concurrances
A four‑Justice dissent argued the releases were essential to secure billions for victims and to avoid chaotic, piecemeal litigation; it warned the majority’s rule could greatly reduce recoveries for many opioid victims and families.
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?